Cumulative Corticosteroid Doses and Osteoporosis in Patients with Multiple Sclerosis

Creative Commons License

Arslan S., Celiker R., KARABUDAK R.

TURKISH JOURNAL OF RHEUMATOLOGY, vol.25, no.4, pp.191-195, 2010 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 4
  • Publication Date: 2010
  • Doi Number: 10.5152/tjr.2010.27
  • Journal Name: TURKISH JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.191-195
  • Hacettepe University Affiliated: Yes

Abstract

Objective: Multiple sclerosis (MS) is an inflammatory demyelinating disorder and corticosteroids used for the treatment of attacks are known to cause osteoporosis. Although osteoporosis is a known potential complication, many patients do not receive treatment to prevent bone loss. The aim of this study was to assess the relationship between cumulative doses of corticosteroids and bone mineral density (BMD) in MS patients.